Stay updated on Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the page as a new version identifier. The Plain Language Summary and Revision: v3.6.4 have been removed, indicating a small administrative update to the study documentation.
    Difference
    0.1%
    Check dated 2026-08-13T01:57:35.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows updated and removed date entries (e.g., 2026-07-30, 2026-08-21, 2026-07-28, 2026-07) indicating maintenance timestamps rather than changes to the study content.
    Difference
    0.2%
    Check dated 2026-08-06T00:19:21.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.3 to v3.6.4 in the history, signaling a new build or update of the page. This reflects deployment/maintenance activity rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-22T16:40:46.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3 on the study entry, representing a minor metadata update to the ClinicalTrials.gov record. It does not alter study details, eligibility, locations, or results.
    Difference
    0.0%
    Check dated 2026-07-01T09:31:35.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The substudy page now shows that recruitment is closed for new participants and adds user-facing sections to help visitors read the study record and find information on joining; a minor heading reform for the Intervention/Treatment section and a page revision note (v3.6.0) are also present.
    Difference
    0.3%
    Check dated 2026-06-16T00:26:24.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.5 and the previous v3.5.4 tag was removed, indicating a new release of the page content. This appears to be an administrative/versioning update rather than a substantive change to study information.
    Difference
    0.0%
    Check dated 2026-06-09T01:17:07.000Z thumbnail image

Stay in the know with updates to Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.